Purchase Order 75N98026P00871
Award Date 8/1/26
Potential Completion Date 7/31/29
Potential Value $7M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Aging awarded a purchase order to Banner Health for $30,240 on June 25, 2026, for the supply of materials for lipids and lipoproteins under a firm fixed-price contract with no small business set-aside. Work is performed in Phoenix, Arizona, with an ultimate completion date of September 30, 2026. The procurement covers non-severable materials supporting NIA's research initiatives, consistent with Banner Health's existing role as a sub-awardee on multiple NIA-funded...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Banner Health for the provision of laboratory supplies for brain tissue. The contract has a potential value of $23,100.00 and a completion date of November 22, 2024. There is no set-aside designation for this contract. Banner Health has previously participated as both a prime contractor and a subcontractor on federal research...
- This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
- The National Institute on Drug Abuse awarded a purchase order to Somalogic Operating Co., Inc. valued at $1,083,600.02 on September 1, 2021 for discovery-based proteomics analysis of archived plasma samples from the Baltimore Longitudinal Study of Aging (BLSA) to identify molecular pathways accelerating pathological phosphorylation of tau in individuals at risk for Alzheimer's disease. Work is performed in Boulder, Colorado. The order calls for aptamer-based proteomic assays on approximately...
- <p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $190,372.20 purchase order to Fujirebio US, Inc. for plasma reagents, calibrators, and controls. Per the original solicitation, Fujirebio will provide assay kits for quantification of serum/plasma biomarkers related to Alzheimer's disease, including beta-amyloid 1-42, beta-amyloid 1-40, and phosphorylated tau 217, using Lumipulse technology on a Lumipulse G1200 instrument. Delivery...
- The National Institute on Aging awarded a purchase order to Histoserv, Inc., a woman-owned small business, for neuropathology characterization services under a Total Small Business set-aside on June 8, 2026, with a ceiling value of $215,567.10. Work is performed in Germantown, Maryland, and runs from June 1, 2026 through May 31, 2027. The order requires processing of 58 large-format human brain autopsy samples for the Brain Atlas Project, including trimming, paraffin embedding, H&E...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm-fixed-price purchase order valued at $26,000 to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. to perform discovery-based proteomic assays on approximately 40 human plasma samples. The work will be performed in Boulder, Colorado over a period of six months from August 2023 through March 2024. The purpose of the assays is to identify proteomic markers of...
- The National Institute on Drug Abuse issued a purchase order to Arizona State University for $970,853.38 on September 18, 2023, for antibody array testing, with an ultimate completion date of September 17, 2027. Work is performed in Tempe, Arizona. The order calls for immunoproteomics services to construct and perform antibody array testing on approximately 32,000 blood samples targeting 300 proteins associated with autoimmune diseases, assessing subclinical and preclinical autoimmune diseases...